RIVOXA 15 mg y 20 mg

Platelet Aggregation Inhibitor

Rivaroxaban

Composition

Each Rivoxa film-coated tablet contains:
Rivaroxaban 15 or 20 mg
Excipients: q.s.

Presentations

Rivoxa 15 mg: Package with 30 coated tablets
Rivoxa 20 mg: Package with 30 coated tablets

Bioequivalent: This product has demonstrated its therapeutic equivalence

Indications

Prevention of cerebrovascular accident and systemic embolism in adult patients with nonvalvular atrial fibrillation, with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, previous cerebrovascular accident or transient ischemic attack.

Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrences of DVT and PE in adults.